Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 325

Sort by

Sort Order Select

Journal Articles

Athn 10 - Novel Variants in Persons with Rare Coagulation Disorders across Hemophilia Treatment Centers in the United States

Diane J. Nugent, Shirley Williams, Suchitra Acharya, Christina Ashburner, Vinod V. Balasa, Nidhi Bhatt, Martin Chandler, Tammuella Chrisentery-Singleton, Nicole Crook, Hilda Ding, Carol Fedor, Ravitharan Krishnadasan, Jonathan C. Roberts, Beverly Schaefer, Ayesha Zia, Amy D. Shapiro

Blood (2024) 144 (Supplement 1): 1216.

https://doi.org/10.1182/blood-2024-201837

Published: 2024

Journal Articles

Long-term Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Who Received Zanubrutinib in the Phase 3 ASPEN Study: A Report from the Zanubrutinib Extension Study

Shirley D'Sa, Meletios A. Dimopoulos, Wojciech Jurczak, Paula Marlton, Stephen P. Mulligan, Bjorn E Wahlin, Magdalena Sobieraj-Teague, Andrew W. Roberts, Constantine S. Tam, Jorge J. Castillo, Heather Allewelt, Radha Prathikanti, Wai Y Chan, Tian Tian, Jingjing Schneider, Remus Vezan, Stephen S. Opat

Blood (2024) 144 (Supplement 1): 3031.

https://doi.org/10.1182/blood-2024-199276

Published: 2024

Journal Articles

Focal Symptomatic Bone Involvement with Waldenström's Macroglobulinaemia and Non-IgM Lymphoplasmacytic Lymphoma

Oliver M Tomkins, Nicole Japzon, Jahanzaib Khwaja, Jindriska Lindsay, Charalampia Kyriakou, Shirley D'Sa

Blood (2024) 144 (Supplement 1): 3023.

https://doi.org/10.1182/blood-2024-209771

Published: 2024

Journal Articles

Feasibility of Advanced Remote Health Monitoring in Waldenstrom Macroglobulinemia: Integrating Wearable Technology and Digital Quality of Life Tracking

Kim Z Summers, Orlando Agrippa, Muna Yusuf, Shirley D'Sa

Blood (2024) 144 (Supplement 1): 2339.

https://doi.org/10.1182/blood-2024-211274

Published: 2024

Journal Articles

Case Management Time in SCD Adults Is Correlated with ED and Ambulatory Utilization and with Behavioral Health Diagnoses, but Not with Hospitalization and Costs

Wally R Smith, Yue May Zhang, Andrea Burton, Shirley Johnson, Daniel M Sop

Blood (2024) 144 (Supplement 1): 2238.

https://doi.org/10.1182/blood-2024-200970

Published: 2024

Journal Articles

Iopofosine I 131 in Previously Treated Patients with Waldenström Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM™)

Blood (2024) 144 (Supplement 1): 861.

https://doi.org/10.1182/blood-2024-200277

Published: 2024

Journal Articles

Expanded Genome-Wide Association Study (GWAS) Identifies Nine Novel Germline Risk Loci for Waldenström Macroglobulinemia (WM) and Lymphoplasmacytic Lymphoma (LPL)

Blood (2024) 144 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2024-211588

Published: 2024

Journal Articles

Improved Outcomes for Pediatric B-ALL but Inferior Survival for T-ALL Using the Same Treatment Protocol: Results of Consecutive Malaysia-Singapore 2003 and 2010 Childhood ALL Trials

Shawn H.R. Lee, Bernice Oh, Prasad Iyer, Yiong Huat Chan, Kean Hui Chiew, Shirley Kow Yin Kham, Michaela Su-Fern Seng, Joyce CM Lam, Lee Lee Chan, Thuan Chong Quah, Hai Peng Lin, Ah Moy Tan, Hany Ariffin, Allen Eng Juh Yeoh

Blood (2024) 144 (Supplement 1): 4192.

https://doi.org/10.1182/blood-2024-193344

Published: 2024

Journal Articles

Challenges in PNH and CAD Management Revealed through Educational Interventions over Three Years

Sumera Ackbarali, Tariqa Ackbarali, Katie Kowalski, Shirley D'Sa, Carlos M de Castro, Satheesh Chonat, Catherine M. Broome

Blood (2024) 144 (Supplement 1): 5087.

https://doi.org/10.1182/blood-2024-211593

Published: 2024

Journal Articles

Planning Mental Health and Social Support Prescreening Assessments for Adult Sickle Cell Disease Patients: Evaluating Readiness for Curative Therapy

Shirley Johnson, Haylee Hartzog, Cecelia R. Valrie, Yue May Zhang, Andrea Burton, Katrina Dalton, Wally R Smith

Blood (2024) 144 (Supplement 1): 7654.

https://doi.org/10.1182/blood-2024-200954

Published: 2024

Journal Articles

Tet2 Deficiency Mitigates Epigenetic Aging in Clonal Hematopoiesis

Sheng Shirley Li, Shilpita Karmakar, Efthymios Motakis, Yang Liu, Kaustav Sengupta, Lamis Naddaf, Travis Roeder, Brandon Vu, Kristina D. Mujica, Eric M. Pietras, James V DeGregori, Jennifer J. Trowbridge, Hideyuki Oguro

Blood (2024) 144 (Supplement 1): 5638.

https://doi.org/10.1182/blood-2024-211767

Published: 2024

Journal Articles

Clinical, Pathological and Outcomes of Mixed Phenotypic Acute Leukemia Patientes:10 Years Real - World Peruvian Data

Gabriela S Chuquillanqui, Cindy Elizabeth Alcarraz, Lourdes Isabel Lopez Chavez, Jule F Vasquez, Shirley Quintana, Raul Mantilla

Blood (2024) 144 (Supplement 1): 5872.

https://doi.org/10.1182/blood-2024-212282

Published: 2024

Journal Articles

Bortezomib-Based Triplet Therapy As First Line Treatment in Newly Diagnosed Multiple Myeloma Patients in Perú

Jule F Vasquez, Naty López Córdova, Claudia Castillo, Alexandra Saavedra, Cindy Calle, Lourdes Isabel Lopez Chavez, Cindy Elizabeth Alcarraz, Pedro Eduardo Lovato Rios, Alejandra La Torre Matuk, Jorge Laboriano, Abner Vilcarano, Carmen Tokumura, Shirley Quintana, Cesar Samanez-Figari, Tatiana Vidaurre

Blood (2024) 144 (Supplement 1): 6997.

https://doi.org/10.1182/blood-2024-210972

Published: 2024

Journal Articles

Social Deprivation Affects Survival in Waldenström Macroglobulinaemia: Experience in the United Kingdom

Jahanzaib Khwaja, Oliver M Tomkins, Nicole Japzon, Jindriska Lindsay, Charalampia Kyriakou, Shirley D'Sa

Blood (2024) 144 (Supplement 1): 7781.

https://doi.org/10.1182/blood-2024-207724

Published: 2024

Journal Articles

Real World Treatment Outcomes in the First Line Management of Waldenström Macroglobulinemia from the Global Patient Derived Data Registry, Whimsical

Ryan Low, Andrew Warden, Michelle Postek, Peter Denardis, Charalampia Kyriakou, Adam J. Olszewski, Marie José Kersten, Josephine M.I. Vos, Sheeba K. Thomas, Shirley D'Sa, Newton Guerin, Carl Harrington, Judith Trotman, Ibrahim Tohidi-Esfahani

Blood (2024) 144 (Supplement 1): 1654.

https://doi.org/10.1182/blood-2024-202820

Published: 2024

Journal Articles

Bing-Neel Syndrome - a Case Series of 46 Patients from the United Kingdom

Oliver M Tomkins, Jahanzaib Khwaja, Nicole Japzon, Shiwen Koay, Chandrashekar Hoskote, Charalampia Kyriakou, Jindriska Lindsay, Michael P Lunn, Shirley D'Sa

Blood (2024) 144 (Supplement 1): 3039.

https://doi.org/10.1182/blood-2024-206989

Published: 2024

Journal Articles

Topic Modeling of Genotyping of Transcriptomes Reveals Collaboration between BTK C481S -Mutant and Wild Type Cells in Btki-Resistant Chronic Lymphocytic Leukemia

Blood (2024) 144 (Supplement 1): 4610.

https://doi.org/10.1182/blood-2024-205727

Published: 2024

Journal Articles

Rethinking Caseloads in Sickle Cell Disease Social Work

Spencer Moorman, Shirley Johnson, Wally R Smith

Blood (2024) 144 (Supplement 1): 7963.

https://doi.org/10.1182/blood-2024-212283

Published: 2024

Journal Articles

Prognostication in IgM and Lymphoplasmacytic Lymphoma Associated Systemic AL Amyloidosis

Jahanzaib Khwaja, Sriram Ravichandran, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Marianna Fontana, Carol Whelan, Philip N Hawkins, Julian Gillmore, Helen J Lachmann, Shameem Mahmood, Shirley D'Sa, Ashutosh D. Wechalekar

Blood (2024) 144 (Supplement 1): 4684.

https://doi.org/10.1182/blood-2024-207522

Published: 2024

Journal Articles

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Blood (2024) 144 (12): 1257–1270.

https://doi.org/10.1182/blood.2024023890

Published: 2024

Includes: Supplemental data

NARROW

Athn 10 - Novel Variants in Persons with Rare Coagulation Disorders across Hemophilia Treatment Centers in the United States

Long-term Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Who Received Zanubrutinib in the Phase 3 ASPEN Study: A Report from the Zanubrutinib Extension Study

Focal Symptomatic Bone Involvement with Waldenström's Macroglobulinaemia and Non-IgM Lymphoplasmacytic Lymphoma

Feasibility of Advanced Remote Health Monitoring in Waldenstrom Macroglobulinemia: Integrating Wearable Technology and Digital Quality of Life Tracking

Case Management Time in SCD Adults Is Correlated with ED and Ambulatory Utilization and with Behavioral Health Diagnoses, but Not with Hospitalization and Costs

Iopofosine I 131 in Previously Treated Patients with Waldenström Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM™)

Expanded Genome-Wide Association Study (GWAS) Identifies Nine Novel Germline Risk Loci for Waldenström Macroglobulinemia (WM) and Lymphoplasmacytic Lymphoma (LPL)

Improved Outcomes for Pediatric B-ALL but Inferior Survival for T-ALL Using the Same Treatment Protocol: Results of Consecutive Malaysia-Singapore 2003 and 2010 Childhood ALL Trials

Challenges in PNH and CAD Management Revealed through Educational Interventions over Three Years

Planning Mental Health and Social Support Prescreening Assessments for Adult Sickle Cell Disease Patients: Evaluating Readiness for Curative Therapy

Tet2 Deficiency Mitigates Epigenetic Aging in Clonal Hematopoiesis

Clinical, Pathological and Outcomes of Mixed Phenotypic Acute Leukemia Patientes:10 Years Real - World Peruvian Data

Bortezomib-Based Triplet Therapy As First Line Treatment in Newly Diagnosed Multiple Myeloma Patients in Perú

Social Deprivation Affects Survival in Waldenström Macroglobulinaemia: Experience in the United Kingdom

Real World Treatment Outcomes in the First Line Management of Waldenström Macroglobulinemia from the Global Patient Derived Data Registry, Whimsical

Bing-Neel Syndrome - a Case Series of 46 Patients from the United Kingdom

Topic Modeling of Genotyping of Transcriptomes Reveals Collaboration between BTK C481S -Mutant and Wild Type Cells in Btki-Resistant Chronic Lymphocytic Leukemia

Rethinking Caseloads in Sickle Cell Disease Social Work

Prognostication in IgM and Lymphoplasmacytic Lymphoma Associated Systemic AL Amyloidosis

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only